Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats (scientific article published on 22 November 2006)

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

Q24646764

The mechanisms of action of PPARs

Q28216953

Glucose transporter proteins in brain: delivery of glucose to neurons and glia

Q28248997

Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats

Q28578691

Immunolocalization of GLUT1 and GLUT3 glucose transporters in primary cultured neurons and glia

Q28579065

Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2

Q28619368

An energy budget for signaling in the grey matter of the brain

Q29616192

Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders

Q31811786

Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain

Q31969991

Survival activity of troglitazone in rat motoneurones

Q32034710

Peroxisome proliferator-activated receptors: from genes to physiology

Q32120242

Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus

Q33691309

Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update

Q34102952

PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer

Q34106716

Peroxisome-proliferator-activated receptor-gamma (PPARgamma) activation protects neurons from NMDA excitotoxicity

Q46915873

Benzodiazepines and β-adrenergic binding to primary cultures of astrocytes and neurons

Q47650409

Glucocorticoids accelerate ATP loss following metabolic insults in cultured hippocampal neurons

Q48121414

Effects of corticosterone administration on local cerebral glucose utilization of rats

Q48123924

Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type?

Q48130941

Alterations of cerebral metabolism in probable Alzheimer's disease: a preliminary study

Q48204022

Corticosteroids in the brain. Cellular and molecular actions

Q48306236

Cryopreservation of rat cortical synaptosomes and analysis of glucose and glutamate transporter activities, and mitochondrial function

Q48378727

Mammalian facilitative glucose transporters: evidence for similar substrate recognition sites in functionally monomeric proteins

Q48418596

Corticosterone accelerates hypoxia- and cyanide-induced ATP loss in cultured hippocampal astrocytes

Q48445268

Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF

Q48453167

Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal

Q48677217

Pharmacologically distinct sodium-dependent L-[3H]glutamate transport processes in rat brain

Q48766189

Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia

Q48945729

Altered glucose metabolism in Alzheimer's disease

Q48956554

The brain-type glucose transporter mRNA is specifically expressed at the blood-brain barrier

Q49133185

Glutamate release in severe brain ischaemia is mainly by reversed uptake.

Q51977738

Energetics of functional activation in neural tissues.

Q51987482

Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease.

Q53240661

Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease.

Q53301872

Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase

Q62003460

Protein determination using bicinchoninic acid in the presence of sulfhydryl reagents

Q68429531

Characterization of the glucose transporter from rat brain synaptosomes

Q70213082

Expression of glucose transporters in rat brain following transient focal ischemic injury

Q71152156

Glucocorticoid Inhibition of Glucose Uptake by Peripheral Tissues: Old and New Evidence, Molecular Mechanisms, and Physiological Significance

Q71763679

Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation

Q71971013

Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate

Q72387905

Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo

Q74339150

The selfish brain: competition for energy resources

Q34323907

Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review

Q34568687

Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity

Q34735622

Therapeutic Potential of Peroxisome Proliferator-Activated Receptor Agonists for Neurological Disease

Q35119232

Mood disorders and allostatic load

Q35189620

When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders

Q35207958

Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones

Q35242884

Rat models of dementia based on reductions in regional glucose metabolism, cerebral blood flow and cytochrome oxidase activity

Q35678444

Regulation of glucose metabolism by nitrosative stress in neural cells.

Q35722451

Glucose transporter expression in the central nervous system: relationship to synaptic function

Q35749608

How astrocytes feed hungry neurons.

Q36217316

PPARs in diseases: control mechanisms of inflammation

Q36353852

Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine

Q36605320

Neurons and microvessels express the brain glucose transporter protein GLUT3.

Q36797339

Acute decrease in net glutamate uptake during energy deprivation.

Q36985138

Oxidative stress and HNE conjugation of GLUT3 are increased in the hippocampus of diabetic rats subjected to stress

Q38459491

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

Q39171874

Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced

Q39531608

Glucose transporter proteins in brain

Q40632966

Glucocorticoids exacerbate the deleterious effects of gp120 in hippocampal and cortical explants

Q41722097

Repeated restraint stress alters hippocampal glutamate uptake and release in the rat.

Q42468429

Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death

Q42482357

Adrenalectomy attenuates stress-induced elevations in extracellular glutamate concentrations in the hippocampus

Q42490767

Effect of glucose starvation on glucose transport in neuronal cells in primary culture from rat brain

Q42505250

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

Q42832963

Quantitative immunohistochemistry of glucose transport protein (Glut3) expression in the rat hippocampus during aging.

Q43576768

Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma

Q43580879

Amyloid beta-peptide inhibits neuronal glucose uptake by preventing exocytosis

Q43690123

Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons

Q43828911

Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart.

Q43935460

Cortical glucose metabolism in Parkinson's and Alzheimer's disease

Q43974906

Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease.

Q44086465

Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes

Q44251886

Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells

Q44512983

Brain-derived neurotrophic factor stimulates energy metabolism in developing cortical neurons.

Q44580787

Inhibition of glutamate release by delaying ATP fall accounts for neuroprotective effects of antioxidants in experimental stroke.

Q44590709

Stimulation of the amygdala by glutamate facilitates corticotropin-releasing factor release from the median eminence and activation of the hypothalamic-pituitary-adrenal axis in stressed rats

Q45095310

The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/nitrosative mediators in brain after acute stress in rats.

Q45272329

Glucocorticoids Inhibit Glucose Transport and Glutamate Uptake in Hippocampal Astrocytes: Implications for Glucocorticoid Neurotoxicity

Q45939833

Thiazolidinediones and their effects on glucose transporters.

Q45983641

Physiological elevations of glucocorticoids potentiate glutamate accumulation in the hippocampus.

Q46023517

Impaired neuronal glucose uptake in pathogenesis of schizophrenia - can GLUT 1 and GLUT 3 deficits explain imaging, post-mortem and pharmacological findings?

Q46672239

P433

issue

P407

language of work or name

English

Q1860

P304

page(s)

1251-1260

P577

publication date

2006-11-22

P1433

published in

Neuropsychopharmacology

Q2261280

P1476

title

Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats

P478

volume

Reverse relations

cites work (P2860)

Q36980014	A Possible Role for Pioglitazone in the Management of Depressive Symptoms in Metabolic Syndrome Patients (EPICAMP Study): A Double Blind, Randomized Clinical Trial.
Q26786354	A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates
Q53087310	Astrocyte-Specific Deletion of Peroxisome-Proliferator Activated Receptor-γ Impairs Glucose Metabolism and Estrous Cycling in Female Mice.
Q88564639	Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats
Q37656600	Chronic stress modulates regional cerebral glucose transporter expression in an age-specific and sexually-dimorphic manner
Q38884449	Cognition and psychopathology in first-episode psychosis: are they related to inflammation?
Q44987446	DNA methylation patterns of peroxisome proliferator-activated receptor gamma gene associated with liver fibrosis and inflammation in chronic hepatitis B.
Q37633887	Dehydroevodiamine·HCl Improves Stress-Induced Memory Impairments and Depression Like Behavior in Rats
Q34134199	Differential sensitivity of prefrontal cortex and hippocampus to alcohol-induced toxicity
Q30490910	Effects of bisphenol-A and other endocrine disruptors compared with abnormalities of schizophrenia: an endocrine-disruption theory of schizophrenia
Q37061840	Epigenetic differences in monozygotic twins discordant for major depressive disorder
Q38755925	Escherichia coli K1 Modulates Peroxisome Proliferator-Activated Receptor γ and Glucose Transporter 1 at the Blood-Brain Barrier in Neonatal Meningitis
Q37783637	Is there a role for the nuclear receptor PPARγ in neuropsychiatric diseases?
Q34105361	Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression
Q28574121	Mangiferin decreases inflammation and oxidative damage in rat brain after stress
Q38777732	Metabolic and Inflammatory Adaptation of Reactive Astrocytes: Role of PPARs
Q41840818	Metabotropic glutamate receptor 5 may be involved in macrophage plasticity
Q47892213	Mismatch in cerebral blood flow and glucose metabolism after the forced swim stress in rats.
Q34226122	Oral administration of royal jelly restores tear secretion capacity in rat blink-suppressed dry eye model by modulating lacrimal gland function
Q38227702	PPARγ and PGC-1α as therapeutic targets in Parkinson's
Q38041907	PPARγ and stress: implications for aging
Q28069549	PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease
Q47739408	Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair
Q91972018	Pioglitazone Improves Mitochondrial Organization and Bioenergetics in Down Syndrome Cells
Q36100305	Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.
Q38272127	Pleiotropic role of PPARγ in intracerebral hemorrhage: an intricate system involving Nrf2, RXR, and NF-κB.
Q37598239	Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia
Q30470076	Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation.
Q30410119	Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice
Q46197073	Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation.
Q48034616	Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation.
Q87398365	Rosiglitazone attenuates cerebral vasospasm and provides neuroprotection in an experimental rat model of subarachnoid hemorrhage
Q42434605	Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease
Q37369927	Stress-induced neuroinflammation: mechanisms and new pharmacological targets.
Q38809746	The Atypical Antipsychotic Paliperidone Regulates Endogenous Antioxidant/Anti-Inflammatory Pathways in Rat Models of Acute and Chronic Restraint Stress
Q35101529	The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria
Q94188870	The Effects of Co-Treatment of 9--Retinoic Acid and 15-Deoxy-Δ (12,14)-prostaglandin J2 on Microglial Activation
Q52343842	Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.
Q38454097	Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research